Skip to main content
Terug
Watch Compare

VACCINEX, INC.

Datakwaliteit: 100%
VCNX
OTC Manufacturing Chemicals
€ 1,50
▲ € 0,30 (25,00%)
6 months return
—
Momentum
Neutral
5Y revenue growth
86,20%

Groei

Revenue Growth (5Y)
86,20%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)5,44%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net Margin-3100,50%
Op. Margin-3117,30%

Veiligheid

Debt / Equity
N/A
Current Ratio0,77
Interest Coverage-9367,50

Waardering

PE (TTM)
-0,15
Boven sectorgemiddelde (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Revenue grew 86,20% annually over 5 years — strong growth
Negative free cash flow of -16,21 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 80,76%
Capital efficient — spends only 3,66% of revenue on capex

Price History

Financiële Trends

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstverassingen

EPS
Reported Estimate
Q32020 Q42020 Q12021 Q22021
Reported -€ 92,40 -€ 54,60 -€ 54,60 -€ 44,10
Estimate -€ 91,35 -€ 78,75 -€ 81,90 -€ 60,90
Verrassing -1,15% +30,67% +33,33% +27,59%

Growth

Rev 5Y: 86,20% · Earnings 1Y: N/A
Revenue Growth (1Y) 5,44% Revenue Growth (3Y) 47,83%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 86,20% Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: -3100,50%
Revenue (TTM) 601.000,0 Net Income (TTM) -18,63 M
ROE N/A ROA -516,11%
Gross Margin N/A Operating Margin -3117,30%
Net Margin -3100,50% Free Cash Flow (TTM) -16,21 M
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 0,77
Debt / Equity N/A Current Ratio 0,77
Interest Coverage -9367,50 Asset Turnover 0,17
Working Capital -1,42 M Tangible Book Value -1,32 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0,15 · EV/EBITDA: N/A
P/E Ratio -0,15 Forward P/E N/A
P/B Ratio N/A P/S Ratio 4,63
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -582,25%
Market Cap 2,78 M Enterprise Value -96.298,0

Per Share

EPS: -8,88 · FCF/Share: -6,06
EPS (Diluted TTM) -8,88 Revenue / Share 0,22
FCF / Share -6,06 OCF / Share -6,05
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 86,98% · CapEx/Rev: 3,66%
CapEx / Revenue 3,66% FCF Conversion 86,98%
SBC-Adj. FCF -16,61 M Growth Momentum -80,76

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 601.000,0 570.000,0 275.000,0 900.000,0 50.000,0
Net Income -18,63 M -20,25 M -19,82 M -22,38 M -28,85 M
EPS (Diluted) -8,88 -43,68 -0,47 — —
Gross Profit — — — — —
Operating Income -18,74 M -22,89 M -19,91 M -22,49 M -28,33 M
EBITDA — — — — —
R&D Expenses 12,55 M 16,57 M 13,98 M 17,16 M 21,55 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 2.000,0 1.000,0 2.000,0 809.000,0 489.000,0
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 2,60 M 3,63 M 7,98 M 9,84 M 11,70 M
Total Liabilities 5,08 M 5,94 M 2,78 M 2,43 M 14,31 M
Shareholders' Equity -2,49 M -2,31 M 5,19 M 7,41 M -26,58 M
Total Debt 0,0 26.000,0 101.000,0 175.000,0 1,13 M
Cash & Equivalents 1,11 M 1,54 M 6,39 M 8,59 M 10,60 M
Current Assets 2,53 M 3,35 M 7,48 M 9,41 M 11,29 M
Current Liabilities 5,08 M 5,92 M 2,54 M 2,26 M 13,18 M

Sectorvergelijking

vs Manufacturing sector mediaan (1605 peers)
Metriek Aandeel Sector Mediaan
P/E -0,2 -1,5
P/B — 1,6
ROE % — -54,5
Net Margin % -3100,5 -41,5
Rev Growth 5Y % 86,2 1,8
D/E — 0,3